Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma Limited has submitted a notice to the National Stock Exchange regarding the schedule of an upcoming company meeting. The announcement, filed under SEBI's Listing Obligation and Disclosure Requirements (Regulation 30), informs the exchange about the planned meeting date and time. The exact details of the meeting—such as whether it is a board meeting to consider results, fundraising, or other corporate matters—are not specified in this brief filing. Investors should wait for further details from the company about the agenda and any decisions likely to emerge from the meeting.
This is a routine compliance disclosure and on its own carries no direct impact on shareholders or stock price. Investors should watch for the follow-up announcement that will contain the actual outcomes or agenda of the meeting, which could influence the stock.